Peifeikang Live Combined Bifidobacterium Triple Capsules

1. Indications and Usage
Intestinal Flora Imbalance: Indicated for the treatment of acute and chronic diarrhea, chronic constipation, and dyspepsia caused by intestinal flora imbalance.
Abdominal Distension: Used to alleviate abdominal bloating associated with gastrointestinal dysfunction.
Innate Toxemia: Also used as an adjunctive therapy for innate toxemia caused by intestinal flora imbalance.
2. Dosage and Administration
Adults: The usual dosage is 2 to 4 capsules per dose, taken twice daily.
Children and Infants: Dosage should be reduced appropriately. For infants who cannot swallow capsules, the capsule can be opened and the powder mixed with warm water or warm milk for administration.
Administration: Capsules should be taken orally with cool or warm water.
Timing: It is generally recommended to take the medication after meals.
3. Mechanism of Action
Biological Barrier: The combination of long Bifidobacterium, Lactobacillus acidophilus, and Enterococcus faecalis forms a biological barrier on the intestinal mucosal surface, preventing pathogenic bacteria from invading the body.
Inhibition of Pathogens: The bacteria inhibit the production of endotoxins by harmful bacteria, maintaining the normal physiological function of the human intestine.
Environmental Regulation: They produce organic acids that lower the intestinal pH, creating an environment that favors the growth of beneficial anaerobic bacteria.
4. Safety and Warnings
Temperature Control: As a live bacterial preparation, it must not be exposed to high temperatures.
Storage: Must be stored in a refrigerator at 2°C to 8°C, protected from light.
Hypersensitivity: Contraindicated in patients with known hypersensitivity to the drug or its excipients.
Pediatric Precautions: Children must be under adult supervision when using this medication.
5. Adverse Reactions and Clinical Research
Common Adverse Reactions: Adverse reactions are generally rare.
Management: No specific management is typically required for mild, transient discomfort.
6. Drug Interactions
Antibiotics: Concurrent use with antibacterial drugs may weaken the efficacy of this product. They should be taken separately with a significant time interval.
Antacids and Adsorbents: Antacids, bismuth preparations, tannic acid, and activated charcoal can inhibit, adsorb, or kill the live bacteria. These should not be taken concurrently.
7. Pharmaceutical Information
Active Ingredients: Long Bifidobacterium, Lactobacillus acidophilus, and Enterococcus faecalis.
Strength: Typically 210 mg per capsule (containing not less than 1.0×10⁷ CFU of each viable bacterium).
Appearance: Hard gelatin capsules containing white to yellow powder with uniform color and occasional spots of bacterial pigment.
Storage: Transport by cold chain, store in a dry and cool place (2°C to 8°C), protected from light.